FAK is overexpressed in many kinds of tumors and contributes to tumorigenicity and tumor development (Sood et al., 2004; Carelli et al., 2006; Yom et al., 2011; Tai et al., 2016). The gene discussed is PTK2; the disease is neoplasm.